Assessment of treatment efficacy in hepatocellular carcinoma: Response rate, delay in progression or none of them

Assessing the response to treatment is a critical aspect in the management of patients with hepatocellular carcinoma (HCC), as is the case in all cancer types [ 1 EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2012; 56: 908-943 Abstract Full Text Full Text PDF PubMed Scopus (4568) Google Scholar , 2 Eisenhauer E.A. Therasse P. Bogaerts J. Schwartz L.H. Sargent D. Ford R. et al. New response evaluation...